|
CO59 Matching-Adjusted Indirect Comparison (MAIC) of Nivolumab + Relatlimab (NIVO+RELA) Vs. BRAF/MEK Inhibitors for First-Line Treatment of BRAF-Mutant Advanced/Metastatic Melanoma (AMEL) |
|
|
|
Titel: |
CO59 Matching-Adjusted Indirect Comparison (MAIC) of Nivolumab + Relatlimab (NIVO+RELA) Vs. BRAF/MEK Inhibitors for First-Line Treatment of BRAF-Mutant Advanced/Metastatic Melanoma (AMEL) |
Auteur: |
Ejzykowicz, F. Palaia, J. Steffen, D. Mattera, M. Zhou, J. Ratto, B. Moshyk, A. Patel, D. Salvatore, A. Garcia-Horton, V. |
Verschenen in: |
Value in health |
Paginering: |
Jaargang 26 () nr. 12S pagina's S24-S25 |
Jaar: |
2023 |
Inhoud: |
|
Uitgever: |
Published by Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|